Developer docs
API playgroundTry for free, no card

Search company profiles

DelveInsight

Full company profile

uuid00056iy

Namestring
DelveInsight
Legal namestring
DelveInsight Business Research LLP
Company typeenum
Private
Founded yearint
2014
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersNew Delhi, India
HQ citystring
New Delhi
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical market research, healthcare consulting, epidemiology forecasting, drug pipeline analysis, competitive intelligence
Industry1 code
PRIMARYHLAGAJAF
Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code1 code
  • Software Publishers5132
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Healthcare Market Research & Consulting
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Market Research Reports
TypeOne Time License
Description

Sale of standardized and customized market research reports covering pharmaceutical and medtech sectors. Reports include market insights, epidemiology forecasts, pipeline analysis, and competitive intelligence across 27 therapeutic areas and 7 major markets.

delveinsight.com
2Healthcare Consulting Services
TypeProfessional Services
Description

Custom consulting engagements including competitive intelligence, portfolio management, forecasting services, epidemiology & market assessment, and pricing & reimbursement analysis for pharmaceutical and biotech clients.

delveinsight.com
3PharmDelve Subscription
TypeSubscription Recurring
Description

Subscription-based platform providing AI-powered access to market reports, clinical trials data, regulatory filings, and epidemiology studies with natural language query capabilities and interactive dashboards.

delveinsight.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details2 tiers
1PharmDelve AI-Powered Platform Subscription
ModelSubscriptionBilling cadenceAnnual
Notes

Subscription-based access to AI-powered pharma intelligence platform with comprehensive report library, natural language query capabilities, and interactive dashboards.

delveinsight.com
2Customized Reports and Consulting Projects
ModelOtherBilling cadenceMulti-year contract
Notes

Custom-built reports tailored to specific geography, emerging markets, or particular therapeutic areas with pricing based on project scope and deliverables.

delveinsight.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

DelveInsight is a healthcare-focused market research and consulting firm that sells standardized and custom market research reports, AI-powered pharma intelligence subscriptions, and strategic consulting services to pharmaceutical, biotechnology, and medical device companies. Its portfolio includes 7,000+ reports spanning 27 therapeutic areas, AI-driven epidemiology databases covering 500+ disease indications, and custom consulting engagements in competitive intelligence, portfolio management, and pricing/reimbursement.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Covers 500+ disease indications with epidemiology forecasts
+2 more records
Product overview1 text field

DelveInsight operates as a healthcare-focused market research and consulting firm offering a portfolio of intelligence products and services. The core offering consists of PharmDelve, an AI-powered subscription platform (Market AI) that provides conversational access to 7000+ market research reports across 27 therapeutic areas, and DelveEpiAI, a separate AI-powered epidemiology database covering 500+ disease indications with 10-year patient burden forecasts. These platforms are complemented by a traditional Report Store for direct report purchases and Healthcare Consulting Services including competitive intelligence, portfolio management, and primary research. The company also provides conference coverage analysis for major medical congresses. The portfolio spans market insights, epidemiology forecasting, pipeline analysis, and strategic consulting for pharmaceutical and medtech clients.

Product and service5 records
1PharmDelve
CategoryPlatform / Subscription Software
Description

AI-powered subscription platform providing enterprise users access to DelveInsight's comprehensive library of pharma market reports, clinical trial analysis, regulatory intelligence, and epidemiology studies across 27 therapeutic areas. Includes conversational Market AI for instant, citation-backed query-based insights.

2DelveEpiAI
CategoryPlatform / Database
Description

AI-powered epidemiology database platform covering 500+ disease indications with 10-year patient burden forecasts across seven major markets (US, EU4, UK, and Japan), integrating curated epidemiology data with KOL insights, natural language querying, and interactive dashboards for patient population assessment and disease trend analysis.

3Report Store
CategoryMarket Research Reports
Description

Repository and digital storefront of 7,000+ healthcare market research reports covering 27 therapeutic areas including oncology, neurology, infectious diseases, and medical devices. Reports are categorized as Market Insight, Epidemiology Insight, Pipeline Insight, Drug Insight, and Competitive Landscape, available with single-user, multi-user, site, and global licenses.

4Healthcare Consulting Services
CategoryConsulting Services
Description

Strategic consulting services including competitive intelligence, portfolio management, desktop research, conference congress intelligence, primary research, pricing and reimbursement analysis, and customized services for pharmaceutical, biotechnology, medical device, and consumer healthcare clients.

5Conference Coverage
CategoryContent / Analysis Service
Description

Analysis and reporting of clinical trial results and developments presented at major medical conferences such as ASCO, providing detailed assessments of key studies, competitive implications, and oncology landscape updates for pharmaceutical and biotech clients.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

GlobalData is a large-scale provider of healthcare market intelligence, epidemiology, and clinical trial data with a comparable pharma-focused report library and subscription model. It directly competes with DelveInsight in pharma market research and pipeline analytics.

TypeBroad incumbent
Description

Clarivate operates the Cortellis and Decision Resources Group (DRG) franchises, which are established pharma intelligence platforms covering pipeline, epidemiology, and market access. It competes with DelveInsight across subscription intelligence and consulting, but at significantly larger scale.

TypeDirect peer
Description

Citeline (formerly Pharma Intelligence/Informa) provides pharma pipeline, clinical trial, and market intelligence products such as Trialtrove and Pharmaprojects. It is a direct competitor to DelveInsight in pharma R&D intelligence and epidemiology.

TypeBroad incumbent
Description

IQVIA is the largest healthcare data and analytics incumbent, offering market intelligence, RWE, and consulting that overlap with DelveInsight's epidemiology, market assessment, and competitive intelligence offerings. It is a much larger competitor with deeper enterprise integrations.

TypeDirect peer
Description

Evaluate, now part of Norstella, provides pharma forecasting, consensus, and pipeline analytics that directly compete with DelveInsight's market forecasting and pipeline insight reports for pharma and biotech clients.

6Mordor Intelligence
TypeEmerging player
Description

Mordor Intelligence is a market research firm publishing syndicated pharma and healthcare reports. It is comparable to DelveInsight in report-store offerings and therapy area coverage, but with less depth in proprietary epidemiology and consulting.

TypeEmerging player
Description

Grand View Research is a syndicated market research publisher covering healthcare and pharma markets. It competes with DelveInsight in standardized report sales, though with less focus on pharma-specific pipeline and epidemiology depth.

TypeDirect peer
Description

Roots Analysis is a niche pharma and life sciences market research firm offering syndicated reports and custom consulting — closely comparable to DelveInsight in scale, customer base (pharma/biotech), and report-store model.

TypeEmerging player
Description

Coherent Market Insights is a syndicated healthcare and pharma market research firm similar in scale to DelveInsight. It competes primarily in standardized reports across therapeutic areas, with less emphasis on AI platforms or consulting.

TypeEmerging player
Description

Polaris Market Research is a market research publisher with a healthcare and pharma vertical. It is comparable to DelveInsight in syndicated report delivery and therapeutic-area coverage, though with limited consulting or AI-platform depth.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

DelveInsight

Healthcare Market Research & Consultingdelveinsight.com

DelveInsight firmographics

Firmographics
Name
DelveInsight
Legal name
DelveInsight Business Research LLP
Website
https://delveinsight.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
101–250 employees
Ownership category
akta.pro rank

DelveInsight industry classification

Industry
Product category
Healthcare Market Research & Consulting
NAICS
Software Publishers (5132)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLAGAJAF
Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • Pharmaceutical market research
  • Healthcare consulting
  • Epidemiology forecasting
  • Drug pipeline analysis
  • Competitive intelligence

Where DelveInsight is headquartered

Location

Headquarters

HQ city
New Delhi
HQ country
India
HQ region
Asia

Offices2 records

Markets served

DelveInsight business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Market Research Reports: Sale of standardized and customized market research reports covering pharmaceutical and medtech sectors. Reports include market insights, epidemiology forecasts, pipeline analysis, and competitive intelligence across 27 therapeutic areas and 7 major markets.
  2. Healthcare Consulting Services: Custom consulting engagements including competitive intelligence, portfolio management, forecasting services, epidemiology & market assessment, and pricing & reimbursement analysis for pharmaceutical and biotech clients.
  3. PharmDelve Subscription: Subscription-based platform providing AI-powered access to market reports, clinical trials data, regulatory filings, and epidemiology studies with natural language query capabilities and interactive dashboards.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualPharmDelve AI-Powered Platform Subscription
OtherMulti-year contractCustomized Reports and Consulting Projects

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

DelveInsight product offering

Product offering

Core offering

DelveInsight is a healthcare-focused market research and consulting firm that sells standardized and custom market research reports, AI-powered pharma intelligence subscriptions, and strategic consulting services to pharmaceutical, biotechnology, and medical device companies. Its portfolio includes 7,000+ reports spanning 27 therapeutic areas, AI-driven epidemiology databases covering 500+ disease indications, and custom consulting engagements in competitive intelligence, portfolio management, and pricing/reimbursement.

Product overview

DelveInsight operates as a healthcare-focused market research and consulting firm offering a portfolio of intelligence products and services. The core offering consists of PharmDelve, an AI-powered subscription platform (Market AI) that provides conversational access to 7000+ market research reports across 27 therapeutic areas, and DelveEpiAI, a separate AI-powered epidemiology database covering 500+ disease indications with 10-year patient burden forecasts. These platforms are complemented by a traditional Report Store for direct report purchases and Healthcare Consulting Services including competitive intelligence, portfolio management, and primary research. The company also provides conference coverage analysis for major medical congresses. The portfolio spans market insights, epidemiology forecasting, pipeline analysis, and strategic consulting for pharmaceutical and medtech clients.

Differentiator

Problem solved

Functional benefit

Products and services

  • PharmDelve AI-powered subscription platform providing enterprise users access to DelveInsight's comprehensive library of pharma market reports, clinical trial analysis, regulatory intelligence, and epidemiology studies across 27 therapeutic areas. Includes conversational Market AI for instant, citation-backed query-based insights.
  • DelveEpiAI AI-powered epidemiology database platform covering 500+ disease indications with 10-year patient burden forecasts across seven major markets (US, EU4, UK, and Japan), integrating curated epidemiology data with KOL insights, natural language querying, and interactive dashboards for patient population assessment and disease trend analysis.
  • Report Store Repository and digital storefront of 7,000+ healthcare market research reports covering 27 therapeutic areas including oncology, neurology, infectious diseases, and medical devices. Reports are categorized as Market Insight, Epidemiology Insight, Pipeline Insight, Drug Insight, and Competitive Landscape, available with single-user, multi-user, site, and global licenses.
  • Healthcare Consulting Services Strategic consulting services including competitive intelligence, portfolio management, desktop research, conference congress intelligence, primary research, pricing and reimbursement analysis, and customized services for pharmaceutical, biotechnology, medical device, and consumer healthcare clients.
  • Conference Coverage Analysis and reporting of clinical trial results and developments presented at major medical conferences such as ASCO, providing detailed assessments of key studies, competitive implications, and oncology landscape updates for pharmaceutical and biotech clients.

Quantifiable outcome

  • Covers 500+ disease indications with epidemiology forecasts
  • +2 more outcomes

Companies that use DelveInsight

Customer profile

Named customers3 records

Segments6 records

Ideal customer profiles3 records

DelveInsight technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature3 records

DelveInsight partnerships and signals

Strategic signal

Scale indicators8 records

Recent moves5 records

Expansion highlights5 records

DelveInsight competitors and assessment

Company assessment

Direct peers

  • GlobalData: GlobalData is a large-scale provider of healthcare market intelligence, epidemiology, and clinical trial data with a comparable pharma-focused report library and subscription model. It directly competes with DelveInsight in pharma market research and pipeline analytics.
  • Citeline (Informa Pharma Intelligence): Citeline (formerly Pharma Intelligence/Informa) provides pharma pipeline, clinical trial, and market intelligence products such as Trialtrove and Pharmaprojects. It is a direct competitor to DelveInsight in pharma R&D intelligence and epidemiology.
  • Evaluate (Norstella): Evaluate, now part of Norstella, provides pharma forecasting, consensus, and pipeline analytics that directly compete with DelveInsight's market forecasting and pipeline insight reports for pharma and biotech clients.
  • Roots Analysis: Roots Analysis is a niche pharma and life sciences market research firm offering syndicated reports and custom consulting — closely comparable to DelveInsight in scale, customer base (pharma/biotech), and report-store model.

Broad incumbents

  • Clarivate (Cortellis / DRG): Clarivate operates the Cortellis and Decision Resources Group (DRG) franchises, which are established pharma intelligence platforms covering pipeline, epidemiology, and market access. It competes with DelveInsight across subscription intelligence and consulting, but at significantly larger scale.
  • IQVIA: IQVIA is the largest healthcare data and analytics incumbent, offering market intelligence, RWE, and consulting that overlap with DelveInsight's epidemiology, market assessment, and competitive intelligence offerings. It is a much larger competitor with deeper enterprise integrations.

Emerging players

  • Mordor Intelligence: Mordor Intelligence is a market research firm publishing syndicated pharma and healthcare reports. It is comparable to DelveInsight in report-store offerings and therapy area coverage, but with less depth in proprietary epidemiology and consulting.
  • Grand View Research: Grand View Research is a syndicated market research publisher covering healthcare and pharma markets. It competes with DelveInsight in standardized report sales, though with less focus on pharma-specific pipeline and epidemiology depth.
  • Coherent Market Insights: Coherent Market Insights is a syndicated healthcare and pharma market research firm similar in scale to DelveInsight. It competes primarily in standardized reports across therapeutic areas, with less emphasis on AI platforms or consulting.
  • Polaris Market Research: Polaris Market Research is a market research publisher with a healthcare and pharma vertical. It is comparable to DelveInsight in syndicated report delivery and therapeutic-area coverage, though with limited consulting or AI-platform depth.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

DelveInsight social profiles

Digital presence

DelveInsight financial estimates

Financial estimate

Revenue estimate

Valuation estimate

DelveInsight leadership team

Management profile

Number of profiles

Profiles1 record

DelveInsight funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

DelveInsight M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DelveInsight

What does DelveInsight do?

DelveInsight is a healthcare-focused market research and consulting firm that sells standardized and custom market research reports, AI-powered pharma intelligence subscriptions, and strategic consulting services to pharmaceutical, biotechnology, and medical device companies. Its portfolio includes 7,000+ reports spanning 27 therapeutic areas, AI-driven epidemiology databases covering 500+ disease indications, and custom consulting engagements in competitive intelligence, portfolio management, and pricing/reimbursement.

Is DelveInsight a public or private company?

DelveInsight is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was DelveInsight founded?

DelveInsight was founded in 2014. It employs 101 to 250 people.

Where is DelveInsight based?

DelveInsight is headquartered in New Delhi, India, in the Asia region.

How does DelveInsight make money?

Three revenue lines are on record. Market Research Reports are the primary driver. The others are healthcare Consulting Services and pharmDelve Subscription.

Who are DelveInsight's main competitors?

Direct peers on record are GlobalData, Citeline (Informa Pharma Intelligence), Evaluate (Norstella) and Roots Analysis. Broad incumbents are Clarivate (Cortellis / DRG) and IQVIA. Emerging players are Mordor Intelligence, Grand View Research, Coherent Market Insights and Polaris Market Research.

Does DelveInsight have an API?

No public API is recorded for DelveInsight.

What industry is DelveInsight in?

DelveInsight's product category is Healthcare Market Research & Consulting. Its primary akta.pro industry code is HLAGAJAF, Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D). Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireCancer Vaccines Clinical Trial Pipeline Boom as 200+ Companies are in the Race for Better Treatments | DelveInsightDelveInsight released its 2026 cancer vaccines pipeline report covering 200+ companies and 200+ pipeline drugs. Positive Phase III results for intismeran autogene in melanoma and encouraging data for TG4050 highlight progress, while combination strategies with checkpoint inhibitors are expected to drive development. Barriers include manufacturing complexity and high costs.Business & FinancialAntithrombotic Drugs Market To Reach USD 89.4 Billion By 2034, Driven By Anticoagulants And Rising Cardiovascular Disease Burden DelveinsightThe global antithrombotic drugs market was valued at USD 46.8 billion in 2025 and is projected to reach USD 89.4 billion by 2034, growing at an 8% CAGR. Anticoagulants accounted for 59% of the market, with North America leading at 44% revenue share. Growth is driven by rising cardiovascular disease burden and DOAC adoption.GlobeNewswireBCMA Targeted Therapies Competitive Landscape Analysis: 100+ Pipeline Therapies Driving Innovation in Therapeutics Segment | DelveInsightDelveInsight's 2026 report covers over 100 BCMA-targeted therapies, including approved drugs like lynvoseltamab and elranatamab, and pipeline candidates. It highlights recent clinical updates, such as Pfizer's Phase III results and AbbVie's BLA submission, and notes challenges like treatment resistance and manufacturing complexity.Business & FinancialBCMA Targeted Therapies Competitive Landscape Analysis: 100+ Pipeline Therapies Driving Innovation In Therapeutics Segment DelveinsightDelveInsight released a competitive landscape report on BCMA-targeted therapies covering over 100 pipeline candidates and approved drugs. The report highlights recent clinical updates, including Pfizer's Phase III results for elranatamab and AbbVie's BLA submission for etentamig. It also notes challenges like treatment resistance and relapse driving next-generation approaches.GlobeNewswireGlobal Injectables Market is Anticipated to Surpass USD 1 Trillion Mark by 2034 | DelveInsightThe global injectables market is projected to grow from USD 765 billion in 2025 to USD 1.6 trillion by 2034, a ~9% CAGR. North America holds the largest share at 39% in 2025, with Asia-Pacific expected to be the fastest-growing region.GlobeNewswireGLP-1 RAs & Incretin-based Therapies Competitive Landscape Analysis: Key Developments by 200+ Companies Shaping the Treatment Landscape | DelveInsightDelveInsight released a 2026 competitive landscape report on GLP-1 receptor agonists and incretin-based therapies, covering over 200 pipeline drugs from more than 180 companies. The report highlights recent trial results, including positive Phase III data for retatrutide and survodutide, and notes that approximately 30+ therapies are in late-stage development.Business & FinancialGlobal Injectables Market Is Anticipated To Surpass USD 1 Trillion Mark By 2034 DelveinsightDelveInsight forecasts the global injectables market to grow from USD 765 billion in 2025 to USD 1.6 trillion by 2034, a ~9% CAGR. North America holds the largest regional share at 39% in 2025, driven by biologics and biosimilars. Growth is fueled by chronic disease prevalence and advances in drug-delivery technologies.GlobeNewswireIdiopathic Inflammatory Myositis Market Set for Strong Growth at 16.8% CAGR Through 2036, Driven by Rising Demand for Targeted Therapies | DelveInsightDelveInsight forecasts the idiopathic inflammatory myositis market to grow at a 16.8% CAGR through 2036, reaching USD 714 million in 2025. The US accounts for about 55% of the 7MM, with approximately 198,000 prevalent cases. Growth is driven by rising disease awareness, diagnostic advances, and a pipeline of targeted therapies.GlobeNewswireSickle Cell Disease Clinical Trial Pipeline Gains Momentum: 45+ Companies Lead the Charge in Pioneering New Treatments | DelveInsightDelveInsight's 2026 report on sickle cell disease pipelines covers 45+ companies developing 50+ drugs, with about 5 in late-stage development. Recent updates include FDA acceptance of mitapivat's sNDA, positive Phase III data for etavopivat, and regulatory designations for BEAM-101 and rilzabrutinib.GlobeNewswireBTK Inhibitors Market to Expand During the Forecast Period (2026–2036) as Targeted Treatments Advance Across B-Cell Malignancies and Autoimmune Disorders | DelveInsightDelveInsight forecasts growth in the BTK inhibitors market through 2036, driven by rising B-cell malignancies and targeted therapy adoption. The US held the largest 2025 share, and recent approvals include Sanofi's WAYRILZ for immune thrombocytopenia and Eli Lilly's expanded Jaypirca indication.